Clinical Trials Browser

OTHER × apatinib × Genitourinary × Clear all

NCT03407976 2020-07-15

APPEASE

Phase 1 Terminated

Adenocarcinoma, Carcinoma, Transitional Cell

NCT02774200 2016-05-17

A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.

Phase 2 Unknown

Carcinoma, Renal Cell